Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Periarticular Bone Loss in Arthritis Is Induced by Autoantibodies Against Citrullinated Vimentin.

Engdahl C, Bang H, Dietel K, Lang SC, Harre U, Schett G.

J Bone Miner Res. 2018 Dec;33(12):2243. doi: 10.1002/jbmr.3611. Epub 2018 Nov 29. No abstract available.

2.

Estrogen induces St6gal1 expression and increases IgG sialylation in mice and patients with rheumatoid arthritis: a potential explanation for the increased risk of rheumatoid arthritis in postmenopausal women.

Engdahl C, Bondt A, Harre U, Raufer J, Pfeifle R, Camponeschi A, Wuhrer M, Seeling M, Mårtensson IL, Nimmerjahn F, Krönke G, Scherer HU, Forsblad-d'Elia H, Schett G.

Arthritis Res Ther. 2018 May 2;20(1):84. doi: 10.1186/s13075-018-1586-z.

3.

The Role of Autoantibodies in Bone Metabolism and Bone Loss.

Hauser B, Harre U.

Calcif Tissue Int. 2018 May;102(5):522-532. doi: 10.1007/s00223-017-0370-4. Epub 2017 Dec 4. Review.

PMID:
29204673
4.

Galectin-3 as a novel regulator of osteoblast-osteoclast interaction and bone homeostasis.

Simon D, Derer A, Andes FT, Lezuo P, Bozec A, Schett G, Herrmann M, Harre U.

Bone. 2017 Dec;105:35-41. doi: 10.1016/j.bone.2017.08.013. Epub 2017 Aug 16.

PMID:
28822790
5.

Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis.

Huang J, Maier C, Zhang Y, Soare A, Dees C, Beyer C, Harre U, Chen CW, Distler O, Schett G, Wollin L, Distler JHW.

Ann Rheum Dis. 2017 Nov;76(11):1941-1948. doi: 10.1136/annrheumdis-2016-210823. Epub 2017 Aug 16.

PMID:
28814429
6.

Cellular and molecular pathways of structural damage in rheumatoid arthritis.

Harre U, Schett G.

Semin Immunopathol. 2017 Jun;39(4):355-363. doi: 10.1007/s00281-017-0634-0. Epub 2017 Jun 8. Review.

PMID:
28597065
7.

Periarticular Bone Loss in Arthritis Is Induced by Autoantibodies Against Citrullinated Vimentin.

Engdahl C, Bang H, Dietel K, Lang SC, Harre U, Schett G.

J Bone Miner Res. 2017 Aug;32(8):1681-1691. doi: 10.1002/jbmr.3158. Epub 2017 May 26. Erratum in: J Bone Miner Res. 2018 Dec;33(12):2243.

8.

Pasteurella multocida Toxin Triggers RANKL-Independent Osteoclastogenesis.

Chakraborty S, Kloos B, Harre U, Schett G, Kubatzky KF.

Front Immunol. 2017 Feb 27;8:185. doi: 10.3389/fimmu.2017.00185. eCollection 2017.

9.

Neurodegeneration Enhances the Development of Arthritis.

Lang SC, Harre U, Purohit P, Dietel K, Kienhöfer D, Hahn J, Baum W, Herrmann M, Schett G, Mielenz D.

J Immunol. 2017 Mar 15;198(6):2394-2402. doi: 10.4049/jimmunol.1601472. Epub 2017 Feb 10.

10.

Regulation of autoantibody activity by the IL-23-TH17 axis determines the onset of autoimmune disease.

Pfeifle R, Rothe T, Ipseiz N, Scherer HU, Culemann S, Harre U, Ackermann JA, Seefried M, Kleyer A, Uderhardt S, Haugg B, Hueber AJ, Daum P, Heidkamp GF, Ge C, Böhm S, Lux A, Schuh W, Magorivska I, Nandakumar KS, Lönnblom E, Becker C, Dudziak D, Wuhrer M, Rombouts Y, Koeleman CA, Toes R, Winkler TH, Holmdahl R, Herrmann M, Blüml S, Nimmerjahn F, Schett G, Krönke G.

Nat Immunol. 2017 Jan;18(1):104-113. doi: 10.1038/ni.3579. Epub 2016 Nov 7.

11.

[Association between bone catabolism and anti-citrullinated protein antibodies in rheumatoid arthritis].

Harre U, Schett G.

Z Rheumatol. 2016 Oct;75(8):809-811. Review. German.

PMID:
27444625
12.

Association of a coding polymorphism in Fc gamma receptor 2A and graft survival in re-transplant candidates.

Arnold ML, Fuernrohr BG, Weiß KM, Harre U, Wiesener MS, Spriewald BM.

Hum Immunol. 2015 Oct;76(10):759-64. doi: 10.1016/j.humimm.2015.09.034. Epub 2015 Sep 30.

PMID:
26429312
13.

Pasteurella multocida toxin- induced osteoclastogenesis requires mTOR activation.

Kloos B, Chakraborty S, Lindner SG, Noack K, Harre U, Schett G, Krämer OH, Kubatzky KF.

Cell Commun Signal. 2015 Sep 14;13:40. doi: 10.1186/s12964-015-0117-7.

14.

Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss.

Harre U, Lang SC, Pfeifle R, Rombouts Y, Frühbeißer S, Amara K, Bang H, Lux A, Koeleman CA, Baum W, Dietel K, Gröhn F, Malmström V, Klareskog L, Krönke G, Kocijan R, Nimmerjahn F, Toes RE, Herrmann M, Scherer HU, Schett G.

Nat Commun. 2015 Mar 31;6:6651. doi: 10.1038/ncomms7651.

15.

Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint.

Ossipova E, Cerqueira CF, Reed E, Kharlamova N, Israelsson L, Holmdahl R, Nandakumar KS, Engström M, Harre U, Schett G, Catrina AI, Malmström V, Sommarin Y, Klareskog L, Jakobsson PJ, Lundberg K.

Arthritis Res Ther. 2014 Aug 12;16(4):R167. doi: 10.1186/ar4683.

16.

Blockade of IL-36 receptor signaling does not prevent from TNF-induced arthritis.

Derer A, Groetsch B, Harre U, Böhm C, Towne J, Schett G, Frey S, Hueber AJ.

PLoS One. 2014 Aug 11;9(8):e101954. doi: 10.1371/journal.pone.0101954. eCollection 2014.

17.

Autoantibody-mediated bone loss.

Harre U, Kittan NA, Schett G.

Curr Osteoporos Rep. 2014 Mar;12(1):17-21. doi: 10.1007/s11914-013-0185-9. Review.

PMID:
24407713
18.

ACPA and bone loss in rheumatoid arthritis.

Kocijan R, Harre U, Schett G.

Curr Rheumatol Rep. 2013 Oct;15(10):366. doi: 10.1007/s11926-013-0366-7. Review.

PMID:
23955066
19.

Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies.

Kleyer A, Finzel S, Rech J, Manger B, Krieter M, Faustini F, Araujo E, Hueber AJ, Harre U, Engelke K, Schett G.

Ann Rheum Dis. 2014 May;73(5):854-60. doi: 10.1136/annrheumdis-2012-202958. Epub 2013 Mar 21.

PMID:
23520034
20.

Bone research in 2012: the ups and downs of bone in health and rheumatic disease.

Harre U, Schett G.

Nat Rev Rheumatol. 2013 Feb;9(2):67-8. doi: 10.1038/nrrheum.2012.219. Epub 2013 Jan 8. Review.

PMID:
23296393
21.

Moonlighting osteoclasts as undertakers of apoptotic cells.

Harre U, Keppeler H, Ipseiz N, Derer A, Poller K, Aigner M, Schett G, Herrmann M, Lauber K.

Autoimmunity. 2012 Dec;45(8):612-9. doi: 10.3109/08916934.2012.719950. Epub 2012 Oct 11.

PMID:
22978425
22.

Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin.

Harre U, Georgess D, Bang H, Bozec A, Axmann R, Ossipova E, Jakobsson PJ, Baum W, Nimmerjahn F, Szarka E, Sarmay G, Krumbholz G, Neumann E, Toes R, Scherer HU, Catrina AI, Klareskog L, Jurdic P, Schett G.

J Clin Invest. 2012 May;122(5):1791-802. doi: 10.1172/JCI60975. Epub 2012 Apr 16.

23.

T cells as key players for bone destruction in gouty arthritis?

Harre U, Derer A, Schorn C, Schett G, Herrmann M.

Arthritis Res Ther. 2011;13(6):135. doi: 10.1186/ar3508. Epub 2011 Dec 2.

24.

[Changes of serum osmolality and conductance in rabbits during the infusion of buffer solutions].

Jährig K, Zöllner H, Fischer V, Zippel U, Giese U, Weyrauch PC, Margies D, Jessat J, Harre U.

Acta Biol Med Ger. 1973;30(3):391-6. German. No abstract available.

PMID:
4762324

Supplemental Content

Support Center